In the News

207 News Items found
Dr. Lisa DeAngelis
Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.
The latest results come from a team of MSK physicians and scientists (from left to right): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio Scaltriti
In the Clinic
Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types.
Graphical representation of cells leaking into bloodstream
In the Lab
Scientists are learning that — in a literal sense — metastasis is wound healing gone wrong.
Dandelion
MSK researchers are learning more about how cancer cells can survive undetected for years only to return in new places. These insights will guide future therapies.
MSK Doctors Andrea Cercek and Michael Foote are seen smiling.
Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK.
Dana Pe'er and Scott Lowe
New MSK research combined sophisticated genetically engineered mouse models and advanced computational methods to map the earliest cell states leading to pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
In the Lab
Targeting this signal with drugs might be one way to stop cancers from spreading.
detail shot of a lab coat with the MSK logo
MSK Research Highlights, June 18, 2025
New MSK research finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is linked to APOBEC3 enzymes; investigates opportunities for restoring sensitivity to endocrine therapy; and finds acupuncture may help prostate cancer survivors wake up less often at night to urinate.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023
New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Finding
New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.